Positions available to study neuroinflammation following stroke and traumatic brain injury, with an emphasis on the role of complement. Projects involve the study of acute and chronic inflammatory reactions and repair processes following brain injury, including in the context of comorbidities (age, smoking, stress). Studies also involve the development and characterization of brain-targeted anti-inflammatory agents. The laboratory utilizes both mouse and in vitro models.
A separate position is also available in a T32 postdoctoral training “Program in Immunology Research and Entrepreneurship”, in which research activities will be complemented by specialized training in entrepreneurship. There are two research areas: 1. Brain injury (see above) and, 2. The role of complement in innate and alloimmune responses following transplantation (heart, lung and limb). For this position, candidates must be a U.S. citizen, non-citizen national, or permanent resident of the United States. Minorities and women are especially encouraged to apply in order to address significant gender and racial/ethnic gaps in entrepreneurial activities in the nation’s biomedical research workforce.
MUSC is located in the beautiful historic district of Charleston, bounded by the Atlantic Ocean and beautiful beaches to the east, and national forests and wildlife refuges to the north and south. MUSC isthe state’s top-ranked medical center.
Internal Number: 222666
About Medical University of South Carolina
MUSC Health annually records more than one million patient encounters, and is highly regarded in many disease areas including neurosciences, cancer care, rheumatology, digestive disorders, heart and vascular care, transplant, women’s health, pediatric medicine, musculoskeletal disorders, psychiatry, eye care, otolaryngology, and respiratory medicine.
Faculty in the College of Medicine are engaged in a variety of basic, clinical, and translational research activities. Total extramural funding for the College of Medicine for the past fiscal year was approximately $204 million.